HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.

AuthorsT Takubo, Y Tani, Y Kubota, S Oguma, T Ueda, H Nakamura, H Shibata, T Masaoka
JournalNihon Gan Chiryo Gakkai shi (Nihon Gan Chiryo Gakkai Shi) Vol. 19 Issue 1 Pg. 1-7 (Feb 20 1984) ISSN: 0021-4671 [Print] Japan
PMID6597236 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytarabine
  • N(4)-palmitoyl cytarabine
Topics
  • Adolescent
  • Adult
  • Child
  • Cytarabine (analogs & derivatives, blood, therapeutic use)
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Leukemia (drug therapy)
  • Leukemia, Lymphoid (drug therapy)
  • Leukemia, Myeloid, Acute (drug therapy)
  • Lymphoma (drug therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: